Article
Emerging drugs in the treatment of pancreatic cancer.
Expert opinion on emerging drugs - 1 Jun 2009
Mahalingam Devalingam, Kelly Kevin R, Swords Ronan T, Carew Jennifer, Nawrocki Steffan T, Giles Francis J
Abstract excerpt
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related death in the US. However, there is a growing belief that novel biological agents could improve survival of patients with this cancer. Gemcitabine-based chemotherapy remains the cornerstone treatment for advanced pancreatic cancers. So far, the current targeted agents that have been used in combination with gemcitabine have failed to...
Topics
- Antineoplastic Agents
- Chemotherapy, Adjuvant
- Drug Delivery Systems
- Drugs, Investigational
- Humans
- Mutation
- Oncogenes
- Pancreatic Neoplasms
- Signal Transduction